Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

Presentation ACC 2025

STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes

Presenter: Marc P. Bonaca

March 29, 2025

Presentation ACC 2020

VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel

Presenter: William Hiatt

March 29, 2020

Presentation

3-year Outcomes of the OLIVE Registry: A Prospective Multicenter Study of CLI

Presenter: O. Iida

September 22, 2015

Presentation

Determinants of Survival and Major AmputationAfter Peripheral Endovascular Intervention for CLI

Presenter: L. Vierthaler

August 04, 2015

Presentation CCVVC 2015

Future Therapeutic Options in the Management of CLI

Presenter: D. Scheinert

June 18, 2015

Presentation

Peripheral Arterial Disease and CLI: Still Poor Outcomes and Lack of Guideline Adherence

Presenter: Holger Reinecke

February 10, 2015

Presentation

Insights from Real-World Femoropopliteal Drug-Coated Balloon (DCB) Treatment: 1-Year Results From IN_PACT Global Clinical Study

Presenter: G.Tepe

February 04, 2015

Presentation

DEB vs Standard Balloon Angioplasty for Infrapopliteal Arterial Revascularization in CLI

Presenter: T. Zeller

October 08, 2014

Presentation TCT 2014

EXCITE ISR: A Prospective, Randomized Trial of Excimer Laser Atherectomy Versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

Presenter: Ajay J. Kirtane, Deepak L. Bhatt, Eric J. Dippel

September 16, 2014

Presentation TCT 2014

CON: There Is No Proof of Efficacy: IN.PACT DEEP Trumps All!

Presenter: Dierk Scheinert

September 15, 2014

Presentation TCT 2014

PRO: IN.PACT DEEP was Flawed!

Presenter: Francesco Liistro

September 15, 2014

Presentation TCT 2014

Impact of Disease Complexity on Technical Approach and Clinical Outcomes: Methodological Considerations for the Evaluation of DCB Safety and Efficacy

Presenter: Gary M. Ansel, Jihad A. Mustapha, Douglas E. Drachman, Peter A. Schneider

September 15, 2014

Presentation TCT 2014

Optimized Comprehensive Wound Care: Elements of a Clinically Excellent and Financially Viable Program

Presenter: Roger M. Greenhalgh, Michael R. Jaff, David P. Slovut, Raghu Kolluri

September 14, 2014

Presentation TCT 2013

Role of Wound Perfusion Assessment in the Management of CLI

Presenter: Mehdi Shishehbor

October 28, 2013

Presentation TCT 2013

Postinterventional Hyperemic Edema: Managing a Frequent Remnant of the Successful CLI Intervention

Presenter: James Joye

October 28, 2013

Presentation TCT 2013

Existing Technologies for CLI: What More Can We Learn by Working Together?

Presenter: Kenneth Rosenfield

October 27, 2013

Presentation

Single-Center Experience with DES for Treatment of Infrapopliteal Occlusive Disease in Patients with CLI: Midterm Follow-up

Presenter: Robert A. Lookstein

April 15, 2013

Presentation

Influence of Race on the Management of Lower Extremity Ischemia

Presenter: Tyler S. Durazzo

March 25, 2013

Presentation

Endovascular Treatment for Infrainguinal Vessels in Patients with CLI: OLIVE Registry

Presenter: O. Iida

February 04, 2013

Presentation TCT 2012

Planning Infrapopliteal Intervention for CLI: Approach and Toolbox Options

Presenter: Mahmood Razavi

October 23, 2012

Advertisement

STRIDE - Semaglutide and walking capacity in people with symptomatic peripheral artery disease and type 2 diabetes

VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel

3-year Outcomes of the OLIVE Registry: A Prospective Multicenter Study of CLI

Determinants of Survival and Major AmputationAfter Peripheral Endovascular Intervention for CLI

Future Therapeutic Options in the Management of CLI

Peripheral Arterial Disease and CLI: Still Poor Outcomes and Lack of Guideline Adherence

Insights from Real-World Femoropopliteal Drug-Coated Balloon (DCB) Treatment: 1-Year Results From IN_PACT Global Clinical Study

DEB vs Standard Balloon Angioplasty for Infrapopliteal Arterial Revascularization in CLI

EXCITE ISR: A Prospective, Randomized Trial of Excimer Laser Atherectomy Versus Balloon Angioplasty for Treatment of Femoropopliteal In-Stent Restenosis

CON: There Is No Proof of Efficacy: IN.PACT DEEP Trumps All!

PRO: IN.PACT DEEP was Flawed!

Impact of Disease Complexity on Technical Approach and Clinical Outcomes: Methodological Considerations for the Evaluation of DCB Safety and Efficacy

Optimized Comprehensive Wound Care: Elements of a Clinically Excellent and Financially Viable Program

Role of Wound Perfusion Assessment in the Management of CLI

Postinterventional Hyperemic Edema: Managing a Frequent Remnant of the Successful CLI Intervention

Existing Technologies for CLI: What More Can We Learn by Working Together?

Single-Center Experience with DES for Treatment of Infrapopliteal Occlusive Disease in Patients with CLI: Midterm Follow-up

Influence of Race on the Management of Lower Extremity Ischemia

Endovascular Treatment for Infrainguinal Vessels in Patients with CLI: OLIVE Registry

Planning Infrapopliteal Intervention for CLI: Approach and Toolbox Options

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content